IRIS
LAMBERTINI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.433
AS - Asia 3.330
NA - Nord America 2.382
SA - Sud America 310
AF - Africa 61
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 28.523
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.547
US - Stati Uniti d'America 2.262
SG - Singapore 1.370
CN - Cina 932
VN - Vietnam 518
FI - Finlandia 305
FR - Francia 290
BR - Brasile 192
BD - Bangladesh 133
HK - Hong Kong 131
DE - Germania 113
MX - Messico 48
AR - Argentina 46
JP - Giappone 45
GB - Regno Unito 38
CA - Canada 37
IN - India 33
NL - Olanda 24
ID - Indonesia 22
EC - Ecuador 20
RU - Federazione Russa 19
IQ - Iraq 18
CH - Svizzera 16
ES - Italia 14
PY - Paraguay 14
ZA - Sudafrica 14
PH - Filippine 13
CL - Cile 12
IE - Irlanda 12
UZ - Uzbekistan 12
AT - Austria 11
PK - Pakistan 11
CO - Colombia 9
KE - Kenya 9
JM - Giamaica 8
JO - Giordania 8
KR - Corea 8
MY - Malesia 8
SA - Arabia Saudita 8
TR - Turchia 8
UA - Ucraina 8
DZ - Algeria 7
MA - Marocco 7
TW - Taiwan 7
VE - Venezuela 7
KW - Kuwait 6
SE - Svezia 6
TH - Thailandia 6
AU - Australia 5
CR - Costa Rica 5
TN - Tunisia 5
AZ - Azerbaigian 4
BE - Belgio 4
DO - Repubblica Dominicana 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
PL - Polonia 3
SI - Slovenia 3
UY - Uruguay 3
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
CU - Cuba 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GR - Grecia 2
LY - Libia 2
MR - Mauritania 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CD - Congo 1
CY - Cipro 1
GF - Guiana Francese 1
GN - Guinea 1
KH - Cambogia 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NO - Norvegia 1
Totale 28.511
Salva come PNG Salva come JPEG
Città #
Genova 9.523
Genoa 8.279
Vado Ligure 1.817
Rapallo 1.564
Singapore 591
San Jose 511
Ashburn 409
Helsinki 284
Council Bluffs 278
Lauterbourg 261
Ho Chi Minh City 153
Beijing 139
Hong Kong 127
New York 125
Hanoi 118
Bordighera 74
Santa Clara 72
Frankfurt am Main 62
St Louis 40
Los Angeles 38
Tokyo 34
Mexico City 29
Haiphong 27
Tianjin 27
Da Nang 25
Chicago 24
Milan 24
Schiffdorf 23
São Paulo 23
Orem 21
Lappeenranta 20
Buffalo 19
Naples 18
Rome 18
Amsterdam 16
Dallas 15
Zurich 15
Guangzhou 14
Dublin 12
Tashkent 12
Atlanta 11
Columbus 11
City of London 10
Curitiba 10
Asunción 9
Bologna 9
Phoenix 9
Shanghai 9
Agawam 8
Hải Dương 8
Quito 8
Shenzhen 8
Amman 7
Houston 7
Johannesburg 7
Nairobi 7
Phủ Lý 7
Seattle 7
Thái Bình 7
Toronto 7
Vienna 7
Baghdad 6
Chengdu 6
Kingston 6
Lahore 6
Miami 6
Montreal 6
Palermo 6
Paris 6
Rio de Janeiro 6
Santiago 6
Bari 5
Biên Hòa 5
Brasília 5
Brescia 5
Campinas 5
Kuwait City 5
Kyiv 5
Medford 5
Ninh Bình 5
Orangeburg 5
Piscataway 5
San José 5
Thái Nguyên 5
Brooklyn 4
Brussels 4
Buenos Aires 4
Bình Phước 4
Can Tho 4
Casablanca 4
Chennai 4
Denver 4
Des Moines 4
Florence 4
Guayaquil 4
Hangzhou 4
Hưng Yên 4
Jakarta 4
Nashville 4
Nuremberg 4
Totale 25.243
Salva come PNG Salva come JPEG
Nome #
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis 230
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast malignancies: a systematic review and meta-analysis 220
The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs) 209
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak 205
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 199
Cancer and fertility preservation: international recommendations from an expert meeting 199
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 195
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study 192
Management of young women with early breast cancer 191
Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies 190
State of the art on oocyte cryopreservation in female cancer patients: A critical review of the literature 184
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence 182
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 179
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate? 175
Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO) 175
Hormonal therapy followed by chemotherapy or the reverse sequence as first-line treatment of hormone-responsive, human epidermal growth factor receptor-2 negative metastatic breast cancer patients: Results of an observational study 175
The PREgnancy and FERtility (PREFER) study: An Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients 174
Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient–level data 171
Adverse events and impact on quality of life of antibody-drug conjugates in the treatment of metastatic breast cancer: A systematic review and meta-analysis 170
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis 170
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis 166
Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences 165
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 164
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study 163
News on the medical treatment of young women with early-stage HER2-negative breast cancer 161
Treatment with aromatase inhibitors and markers of cardiovascular disease 160
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials 160
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 160
Adherence to guidelines in requesting oncotype DX in a publicly funded health care system 160
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patients 160
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 158
New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an "ESMO Open-Cancer Horizons" Series 158
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study 158
Pharmacotherapy to protect ovarian function and fertility during cancer treatment 156
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial 155
Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients 155
Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients 154
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients 151
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 150
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials 149
Gonadotropin Releasing Hormone Agonists Have an Anti-apoptotic Effect on Cumulus Cells 149
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis 148
Exploring the safety of chemotherapy for treating breast cancer during pregnancy 148
Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients 148
Letrozole withdrawal response in locally advanced breast cancer 147
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review 147
Adjuvant trastuzumab: a 10-year overview of its benefit 146
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 145
Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting 144
Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors? 143
Safety and feasibility of fasting‐mimicking diet and effects on nutritional status and circulating metabolic and inflammatory factors in cancer patients undergoing active treatment 143
Fertility and pregnancy issues in BRCA-mutated breast cancer patients 142
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis 141
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy 141
Fertility, sexuality and cancer in young adult women 141
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer 141
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients 140
Trastuzumab emtansine (T-DM1) as adjuvant treatment of HER2-positive early breast cancer: safety and efficacy 139
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis 138
Another step towards improving oncofertility counselling of young women with Hodgkin's lymphoma 138
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial 137
Reply to the letter to the editor 'Can ovarian suppression with gonadotropin releasing hormone analogs (GnRHa) preserve fertility in cancer patients?' by Rodriguez-Wallberg et al. 136
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in young BRCA-mutated breast cancer patients 136
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial 136
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer 136
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial 136
Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives 135
Targeted agents for cancer treatment during pregnancy 134
Reply to the letter "Safety of fertility preservation in women with breast cancer" 133
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials 133
Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects 133
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 132
Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology 132
Dose-dense adjuvant chemotherapy in HER2-positive early breast cancer patients before and after the introduction of trastuzumab: exploratory analysis of the GIM2 trial 132
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations 131
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis 130
Follow-up strategies for women treated for early breast cancer 130
Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do? 127
Implementing the hub and spoke model for the oncofertility units 127
Tumor-to-nipple Distance Should Not Preclude Nipple-sparing Mastectomy in Breast Cancer Patients. Personal Experience and Literature Review 126
Comparing the gonadotoxicity of multiple breast cancer regimens: Important understanding for managing breast cancer in pre-menopausal women 126
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 125
Long-term safety of pregnancy following breast cancer according to estrogen receptor status 125
Ovarian suppression using luteinizing hormonereleasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: A meta-analysis of randomized studies 124
Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors 124
What medical oncologist residents think about the Italian speciality schools: A survey of the Italian Association of Medical Oncology (AIOM) on educational, clinical and research activities 124
Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients 124
Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy 124
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research Activities 124
Triple-negative breast cancer: Current perspective on the evolving therapeutic landscape 123
Breast Cancer Surgery in the COVID-19 Pandemic: Validation of a Preventive Program for Patients and Health Care Workers 123
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate 123
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trial 122
Current practices in oncofertility counseling: updated evidence on fertility preservation and post-treatment pregnancies in young women affected by early breast cancer 122
Approaches to Fertility Preservation for Young Women With Breast Cancer 120
How I treat metastatic triple-negative breast cancer 120
Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer 119
Impact of ovarian function suppression in premenopausal women with estrogen receptor-positive early breast cancer 117
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review 117
Radiation therapy for young women with early breast cancer: Current state of the art 116
Totale 14.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.215
article - articoli 109.836
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 379
Totale 220.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021317 0 0 0 0 0 0 0 0 0 0 140 177
2021/20222.453 166 82 108 237 58 230 82 523 278 259 98 332
2022/20232.027 265 194 38 162 269 260 53 186 376 16 186 22
2023/20241.623 53 153 38 198 111 143 93 112 87 113 135 387
2024/20254.968 141 376 97 278 671 541 525 768 242 250 490 589
2025/202610.847 1.011 471 1.365 962 1.217 922 1.668 569 840 1.176 646 0
Totale 29.588